379 related articles for article (PubMed ID: 32483464)
21. Tetraspanin CD82 represses Sp1-mediated Snail expression and the resultant E-cadherin expression interrupts nuclear signaling of β-catenin by increasing its membrane localization.
Lee MS; Byun HJ; Lee J; Jeoung DI; Kim YM; Lee H
Cell Signal; 2018 Dec; 52():83-94. PubMed ID: 30189244
[TBL] [Abstract][Full Text] [Related]
22. CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation.
Zhang P; Feng S; Liu G; Wang H; Fu A; Zhu H; Ren Q; Wang B; Xu X; Bai H; Dong C
Oncogene; 2016 Sep; 35(38):5056-5069. PubMed ID: 27041584
[TBL] [Abstract][Full Text] [Related]
23. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
[TBL] [Abstract][Full Text] [Related]
24. CD82 and Gangliosides Tune CD81 Membrane Behavior.
Fernandez L; Malrieu M; Bénistant C; Dosset P; Rubinstein E; Odintsova E; Berditchevski F; Milhiet PE
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445169
[TBL] [Abstract][Full Text] [Related]
25. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse.
Todeschini AR; Dos Santos JN; Handa K; Hakomori SI
J Biol Chem; 2007 Mar; 282(11):8123-33. PubMed ID: 17215249
[TBL] [Abstract][Full Text] [Related]
26. Exosomal protein CD82 as a diagnostic biomarker for precision medicine for breast cancer.
Wang X; Zhong W; Bu J; Li Y; Li R; Nie R; Xiao C; Ma K; Huang X; Li Y
Mol Carcinog; 2019 May; 58(5):674-685. PubMed ID: 30604894
[TBL] [Abstract][Full Text] [Related]
27. Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation.
Delaguillaumie A; Harriague J; Kohanna S; Bismuth G; Rubinstein E; Seigneuret M; Conjeaud H
J Cell Sci; 2004 Oct; 117(Pt 22):5269-82. PubMed ID: 15454569
[TBL] [Abstract][Full Text] [Related]
28. Tetraspanin CD82 is necessary for muscle stem cell activation and supports dystrophic muscle function.
Hall A; Fontelonga T; Wright A; Bugda Gwilt K; Widrick J; Pasut A; Villa F; Miranti CK; Gibbs D; Jiang E; Meng H; Lawlor MW; Gussoni E
Skelet Muscle; 2020 Nov; 10(1):34. PubMed ID: 33243288
[TBL] [Abstract][Full Text] [Related]
29. CD82 endocytosis and cholesterol-dependent reorganization of tetraspanin webs and lipid rafts.
Xu C; Zhang YH; Thangavel M; Richardson MM; Liu L; Zhou B; Zheng Y; Ostrom RS; Zhang XA
FASEB J; 2009 Oct; 23(10):3273-88. PubMed ID: 19497983
[TBL] [Abstract][Full Text] [Related]
30. Tetraspanins regulate the protrusive activities of cell membrane.
Bari R; Guo Q; Xia B; Zhang YH; Giesert EE; Levy S; Zheng JJ; Zhang XA
Biochem Biophys Res Commun; 2011 Dec; 415(4):619-26. PubMed ID: 22079629
[TBL] [Abstract][Full Text] [Related]
31. A Novel Function of CD82/KAI1 in Sialyl Lewis Antigen-Mediated Adhesion of Cancer Cells: Evidence for an Anti-Metastasis Effect by Down-Regulation of Sialyl Lewis Antigens.
Yoshihama N; Yamaguchi K; Chigita S; Mine M; Abe M; Ishii K; Kobayashi Y; Akimoto N; Mori Y; Sugiura T
PLoS One; 2015; 10(4):e0124743. PubMed ID: 25923697
[TBL] [Abstract][Full Text] [Related]
32. KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
Malik FA; Sanders AJ; Jiang WG
Histol Histopathol; 2009 Apr; 24(4):519-30. PubMed ID: 19224455
[TBL] [Abstract][Full Text] [Related]
33. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
34. Tetraspanin CD82 Correlates with and May Regulate S100A7 Expression in Oral Cancer.
Reddi KK; Zhang W; Shahrabi-Farahani S; Anderson KM; Liu M; Kakhniashvili D; Wang X; Zhang YH
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473906
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation.
Ruseva Z; Geiger PX; Hutzler P; Kotzsch M; Luber B; Schmitt M; Gross E; Reuning U
Exp Cell Res; 2009 Jun; 315(10):1759-71. PubMed ID: 19371633
[TBL] [Abstract][Full Text] [Related]
36. Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1.
Odintsova E; Sugiura T; Berditchevski F
Curr Biol; 2000 Aug; 10(16):1009-12. PubMed ID: 10985391
[TBL] [Abstract][Full Text] [Related]
37. KAI1/CD82, a tumor metastasis suppressor.
Liu WM; Zhang XA
Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
[TBL] [Abstract][Full Text] [Related]
38. Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration.
Zhang XA; He B; Zhou B; Liu L
J Biol Chem; 2003 Jul; 278(29):27319-28. PubMed ID: 12738793
[TBL] [Abstract][Full Text] [Related]
39. The inner loop of tetraspanins CD82 and CD81 mediates interactions with human T cell lymphotrophic virus type 1 Gag protein.
Mazurov D; Heidecker G; Derse D
J Biol Chem; 2007 Feb; 282(6):3896-903. PubMed ID: 17166843
[TBL] [Abstract][Full Text] [Related]
40. GM2/GM3 controls the organizational status of CD82/Met microdomains: further studies in GM2/GM3 complexation.
Santos RCM; Lucena DMS; Loponte HFBR; Alisson-Silva F; Dias WB; Lins RD; Todeschini AR
Glycoconj J; 2022 Oct; 39(5):653-661. PubMed ID: 35536494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
